Prochlorperazine recalls

The FDA has published 2 recalls involving Prochlorperazine since 2023. The latest was reported on 16 Apr 2025. Most were for potency & assay. Glenmark Pharmaceuticals Inc., USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2023

Last 12 months0reported

Class I00% of total

Ongoing1latest 16 Apr 2025

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 1 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 1 50%Class III 1 50%

Why prochlorperazine is recalled

Potency & Assay150%
Manufacturing (CGMP) Deviations150%

Companies

By year

2025150%
2023150%

Ongoing prochlorperazine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
16 Apr 2025Drug	CLASS II	Prochlorperazine Maleate Tablets, 10mg recalled	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide

All prochlorperazine recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
16 Apr 2025Drug	CLASS II	Prochlorperazine Maleate Tablets, 10mg recalled	Glenmark Pharmaceuticals Inc., USA	Manufacturing (CGMP) Deviations	Nationwide
11 Jan 2023Drug	CLASS III	Prochlorperazine Maleate Tablets, USP 5mg recalled by Jubilant CadistaProchlorperazine Maleate	Jubilant Cadista Pharmaceuticals	Potency & Assay	Nationwide

Should you stop taking Prochlorperazine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.